HopeStage
Back to all studies
CompletedNCT00621842

Lamotrigine formulations for bipolar depression in older adults

About this title

Lamotrigine for Symptoms of Geriatric Bipolar Depression

Read the official source — NCT00621842
Medication studyAges 60+United StatesBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 60 years.

Listed locations
White Plains and 4 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2008
Recruitment status
Completed
Enrollment listed in the registry
57
Sponsor
University Hospitals Cleveland Medical Center
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
Over 60 Years
Official registry ID
NCT00621842
Official title
Show the full official title

Open-label, Prospective Trial of Lamotrigine for Symptoms of Geriatric Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

White Plains · Cleveland · Philadelphia

2 more locations
  • Pittsburgh
  • Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospitals Cleveland Medical Center, a university.

Did this study involve medication?

Yes. The study involved medication, including Lamotrigine regular tablet formulation and Lamotrigine novel formulation.

Who was this study for?

Listed age limits: from 60 years.

Want to explore more studies?

Explore studies